3-methoxytyramine has been researched along with sk&f-38393 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brusniak, MY; DuRand, CJ; Huang, WH; Neve, KA; Pearlman, RS; Teeter, MM; Wiens, BL; Wilcox, DM; Wilcox, RE | 1 |
| Altar, CA; Boyar, WC; Gerhardt, SC; Liebman, JM; Wasley, A; Wood, PL | 1 |
| Altar, CA; Boyar, WC | 1 |
3 other study(ies) available for 3-methoxytyramine and sk&f-38393
| Article | Year |
|---|---|
CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors.
Topics: Alanine; Amino Acid Substitution; Animals; Bromocriptine; Combinatorial Chemistry Techniques; Dopamine Agonists; Models, Molecular; Pergolide; Point Mutation; Radioligand Assay; Rats; Receptors, Dopamine D2; Recombinant Proteins; Serine; Structure-Activity Relationship; Tumor Cells, Cultured | 2000 |
Dopamine neurochemical profile of atypical antipsychotics resembles that of D-1 antagonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Behavior, Animal; Benzazepines; Brain Chemistry; Dopamine; Dopamine Antagonists; Male; Mice; Motor Activity; Pargyline; Stereotyped Behavior | 1988 |
Modulation of in vivo dopamine release by D2 but not D1 receptor agonists and antagonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Benzopyrans; Brain; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Ergolines; Haloperidol; Homovanillic Acid; Kinetics; Male; Metoclopramide; Mice; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1987 |